| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced topics in evidence-based urological oncology: Using results of a subgroup analysis
|
Scales Jr., Charles D.
|
|
2011
|
29 |
4 |
p. 462-466
5 p.
|
artikel
|
| 2 |
Advanced topics in evidence-based urologic oncology: Economic analysis
|
Vogel, Bruce
|
|
2011
|
29 |
4 |
p. 454-461
8 p.
|
artikel
|
| 3 |
Advanced topics in evidence-based urologic oncology: Surrogate endpoints
|
Lavallée, Luke T.
|
|
2011
|
29 |
4 |
p. 447-453
7 p.
|
artikel
|
| 4 |
A multidisciplinary approach to the management of urologic malignancies: Does it influence diagnostic and treatment decisions?
|
Kurpad, Raj
|
|
2011
|
29 |
4 |
p. 378-382
5 p.
|
artikel
|
| 5 |
Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract
|
Ku, Ja Hyeon
|
|
2011
|
29 |
4 |
p. 383-387
5 p.
|
artikel
|
| 6 |
Commentary on “Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity”. Powell IJ, Bock CH, Ruterbusch JJ, Sakr W, Wayne State University School of Medicine and Karmanos Cancer Institute, Detroit, MI
|
Eggener, Scott
|
|
2011
|
29 |
4 |
p. 471-472
2 p.
|
artikel
|
| 7 |
Commentary on “Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival”. Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, Fiore C, Qiu W, Fiorentino M, Finn S, Penney KL, Eisenstein A, Schumacher FR, Mucci LA, Stampfer MJ, Giovannucci E, Loda M, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
|
Eggener, Scott
|
|
2011
|
29 |
4 |
p. 471-
1 p.
|
artikel
|
| 8 |
Commentary on “Focal laser ablation for prostate cancer followed by radical prostatectomy: Validation of focal therapy and imaging accuracy”. Lindner U, Lawrentschuk N, Weersink RA, Davidson SR, Raz O, Hlasny E, Langer DL, Gertner MR, Van der Kwast T, Haider MA, Trachtenberg J, Surgical Oncology, Urology Division, University Health Network, University of Toronto, Toronto, Canada
|
Eggener, Scott
|
|
2011
|
29 |
4 |
p. 470-471
2 p.
|
artikel
|
| 9 |
Commentary on “Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study”. Stattin P, Holmberg E, Johansson JE, Holmberg L, Adolfsson J, Hugosson J, National Prostate Cancer Register (NPCR) of Sweden, Urology and Andrology, Department of Surgical and Perioperative Science, Umeå University Hospital, Umeå, Sweden. (Collaborators (15): Stattan P, Widmark A, Karlsson S, Törnblom M, Adolfsson J, Bill-Axelson A, Andrén O, Robinson D, Pettersson B, Hugosson J, Damber JE, Bratt O, Ahlgren G, Egevad L, Ehrnström R)
|
Eggener, Scott
|
|
2011
|
29 |
4 |
p. 469-
1 p.
|
artikel
|
| 10 |
Commentary on “Statin use and risk of prostate cancer recurrence in men treated with radiation therapy”. Gutt R, Tonlaar N, Kunnavakkam R, Karrison T, Weichselbaum RR, Liauw SL, Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL
|
Eggener, Scott
|
|
2011
|
29 |
4 |
p. 470-
1 p.
|
artikel
|
| 11 |
Contents
|
|
|
2011
|
29 |
4 |
p. v-vii
nvt p.
|
artikel
|
| 12 |
Dual targeting of Bcl-2 and VEGF: A potential strategy to improve therapy for prostate cancer
|
Anai, Satoshi
|
|
2011
|
29 |
4 |
p. 421-429
9 p.
|
artikel
|
| 13 |
Editorial Board
|
|
|
2011
|
29 |
4 |
p. iii-
1 p.
|
artikel
|
| 14 |
Epothilones in prostate cancer
|
Kelly, William K.
|
|
2011
|
29 |
4 |
p. 358-365
8 p.
|
artikel
|
| 15 |
Erratum to “Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide Synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis”
|
Sanli, Oner
|
|
2011
|
29 |
4 |
p. 467-
1 p.
|
artikel
|
| 16 |
Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637
|
Hu, Zheng
|
|
2011
|
29 |
4 |
p. 430-435
6 p.
|
artikel
|
| 17 |
Information for Authors
|
|
|
2011
|
29 |
4 |
p. IBC-
1 p.
|
artikel
|
| 18 |
Introduction to a new series: Advanced topics in evidence-based urologic oncology
|
Canfield, Steven E.
|
|
2011
|
29 |
4 |
p. 446-
1 p.
|
artikel
|
| 19 |
Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and 124I-cG250 PET/CT
|
Lawrentschuk, Nathan
|
|
2011
|
29 |
4 |
p. 411-420
10 p.
|
artikel
|
| 20 |
Is the apical soft tissue margin a better predictor of biochemical recurrence than the surgical specimen?
|
Godoy, Guilherme
|
|
2011
|
29 |
4 |
p. 388-392
5 p.
|
artikel
|
| 21 |
Masthead
|
|
|
2011
|
29 |
4 |
p. iv-
1 p.
|
artikel
|
| 22 |
Modified N-shaped ileal neobladder after radical cystectomy
|
Gamal, Wael M.
|
|
2011
|
29 |
4 |
p. 366-371
6 p.
|
artikel
|
| 23 |
Narrow band imaging cystoscopy
|
Herr, Harry H.
|
|
2011
|
29 |
4 |
p. 353-357
5 p.
|
artikel
|
| 24 |
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostate
|
Bittner, Nathan
|
|
2011
|
29 |
4 |
p. 398-404
7 p.
|
artikel
|
| 25 |
Robotic cystectomy and the Internet: Separating fact from fiction
|
Pruthi, Raj S.
|
|
2011
|
29 |
4 |
p. 393-397
5 p.
|
artikel
|
| 26 |
Role of PSA velocity in predicting pathologic upgrade for Gleason 6 prostate cancer
|
Krane, L. Spencer
|
|
2011
|
29 |
4 |
p. 372-377
6 p.
|
artikel
|
| 27 |
Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines
|
Dizeyi, Nishtman
|
|
2011
|
29 |
4 |
p. 436-445
10 p.
|
artikel
|
| 28 |
Survey Section Editorial Board
|
|
|
2011
|
29 |
4 |
p. 468-
1 p.
|
artikel
|
| 29 |
Treatment of brain metastases from renal cell cancer
|
Nieder, Carsten
|
|
2011
|
29 |
4 |
p. 405-410
6 p.
|
artikel
|
|
Tijdschrift beschrijving